Literature DB >> 16614082

Glucose induces glucagon release pulses antisynchronous with insulin and sensitive to purinoceptor inhibition.

Eva Grapengiesser1, Albert Salehi, Saleem S Qader, Bo Hellman.   

Abstract

Both increase of the glucose concentration and activation of purinoceptors are known to affect pancreatic alpha-cells. Effects obtained with various purino derivatives at 2.8 and 8.3 mmol/liter glucose have been taken to indicate that external ATP is less potent than adenosine as a stimulator of glucagon release. However, when making a corresponding comparison at 20 mmol/liter glucose, we observed marked stimulation of glucagon release from isolated rat islets with 100 micromol/liter adenosine-5-O-2-thiodiphosphate but inhibition with 10 micromol/liter adenosine. Analyses of 30-sec samples of perfusate from rat pancreas indicated that a rise of the glucose concentration from 3 to 20 mmol/liter rapidly induces a glucagon peak followed by regular 4- to 5-min pulses. The glucagon pulses preceded those of insulin with a phase shift (1.8 +/- 0.1 min) near half the interpeak interval. Because of the antisynchrony, the maximal glucagon effect on liver cells will be manifested during periods with low concentrations of insulin. In support for the idea that neural P2Y(1) receptors are important for coordinating the secretory activity of the islets, both the insulin and glucagon pulses disappeared in the presence of the purinoceptor inhibitor MRS 2179 (10 micromol/liter). However, in contrast to what was observed for insulin, MRS 2179 lowered average glucagon release to the level of the oscillatory nadirs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614082     DOI: 10.1210/en.2005-1431

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Paracrine regulation of glucagon secretion: the β/α/δ model.

Authors:  Margaret Watts; Joon Ha; Ofer Kimchi; Arthur Sherman
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-02       Impact factor: 4.310

2.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

Review 3.  Regulatory role of adenosine in insulin secretion from pancreatic β-cells--action via adenosine A₁ receptor and beyond.

Authors:  Tomasz Szkudelski; Katarzyna Szkudelska
Journal:  J Physiol Biochem       Date:  2014-11-30       Impact factor: 4.158

4.  Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion.

Authors:  Fariborz Parandeh; Stefan Amisten; Gaurav Verma; Israa Mohammed Al-Amily; Pontus Dunér; Albert Salehi
Journal:  J Biol Chem       Date:  2020-08-27       Impact factor: 5.157

5.  Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

6.  Purinergic P2Y1 receptors take centre stage in autocrine stimulation of human beta cells.

Authors:  Anders Tengholm
Journal:  Diabetologia       Date:  2014-10-03       Impact factor: 10.122

Review 7.  Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.

Authors:  L S Farhy; A L McCall
Journal:  Diabetes Obes Metab       Date:  2011-10       Impact factor: 6.577

8.  Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells.

Authors:  Matthias Braun; Reshma Ramracheya; Martin Bengtsson; Anne Clark; Jonathan N Walker; Paul R Johnson; Patrik Rorsman
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

9.  Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.

Authors:  Leon S Farhy; Zhongmin Du; Qiang Zeng; Paula P Veldhuis; Michael L Johnson; Kenneth L Brayman; Anthony L McCall
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

Review 10.  Pulsatility of insulin release--a clinically important phenomenon.

Authors:  Bo Hellman
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.